Although the actions of GLP-1 on the beta-cell are preserved yet modestly diminished in T2DM, the diabetic alpha-cell retains near normal responsivity to low dose GLP-1 infusion, with inhibition of glucagon secretion seen to a similar extent in diabetic vs
Stay Hydrated So simple, so important, but so often overlooked
Despite significant progress observed in clinical trial development, there remains a scarcity of published clinical data, particularly regarding long-term safety, efficacy across diverse populations, and real-world effectiveness
Sitagliptin is a P-gp substrate but does not inhibit P-gp mediated transport of digoxin
GLP-1 receptor agonists mimic the action of a natural hormone called glucagon-like peptide-1, which is released in response to food intake
However, liraglutide offers the cardiovascular and metabolic benefits common to all GLP-1 medications, which phentermine does not